Wide Variation Between Hospitals in Vena Cava Filter Use
To prevent migration of blood clots to the lungs in patients with acute venous thromboembolism (VTE), the frequency of vena cava filter (VCF) use appears to vary widely.
To prevent migration of blood clots to the lungs in patients with acute venous thromboembolism (VTE), the frequency of vena cava filter (VCF) use appears to vary widely.
‘The 56th annual conference of Indian Society of Hematology & Blood Transfusion, began in Bangalore on Friday, November 6, 2015. Multiple scientific workshops will focus on sharing innovations in bone marrow transplants, blood cancer and other blood related disorders.’
Tweet it Now
During the three-day conference, health experts from the US, Germany, Britain, Canada, France, Australia, Singapore, Greece, Italy and Oman will also share knowledge on hematology and related disciplines. The conference will also exchange information, technological advances and scientific achievements in platelet disorders, acute leukemia - pediatric and adult, lymphomas cancer (cancer of the lymph system), RBC & WBC issues, blood transplants and other relevant topics. About 200 national faculty and over 1,500 delegates are expected to attend the conference. The event is organized by the Karnataka chapter of Indian Society of Hematology & Blood Transfusion and Narayana Health City.
Source-IANS
Mechanism That Decides the Life of Immune-Suppressing Cells Identified
Australian researchers have revealed that they have managed to uncover the mechanism through which cells which suppress immune responses live or die.
Australian researchers have revealed that they have managed to uncover the mechanism through which cells which suppress immune responses live or die.
Focus for Sickle Cell Science Should be Development of Anti-Sickling Therapies
One of the physicians specializing in sickle cell disease says that pain is an undeniable focal point for patients with the condition.
One of the physicians specializing in sickle cell disease says that pain is an undeniable focal point for patients with the condition.
Genetic Decoy That Prevents Immune System from Neutralizing Gene Therapy Benefits Developed
Researchers revealed that they have managed to develop a bioengineered decoy which can fool the immune system.
Researchers revealed that they have managed to develop a bioengineered decoy which can fool the immune system.
